George Kemble

Insider Reports History

Entity
Individual
Location
Sagimet Biosciences Inc., 155 Bovet Rd., Ste. 303, San Mateo, CA
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Kemble:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Executive Chairman, Director Series A Common Stock 156K $641K $4.10 Nov 17, 2023 Direct
Sagimet Biosciences Inc. Executive Chairman, Director Series A Common Stock 119K $376K $3.17 Jul 23, 2024 Direct
Sagimet Biosciences Inc. Executive Chairman, Director Stock Option (Right to Buy) 0 Sep 7, 2023 Direct

Insider Reports Filed by George Kemble

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMT Sagimet Biosciences Inc. Jul 23, 2024 1 -$74.8K 4 Jul 25, 2024 Executive Chairman, Director
SGMT Sagimet Biosciences Inc. Jul 19, 2024 1 -$43.6K 4 Jul 23, 2024 Executive Chairman, Director
SGMT Sagimet Biosciences Inc. Nov 17, 2023 1 $0 4 Nov 21, 2023 Executive Chairman, Director
SGMT Sagimet Biosciences Inc. Sep 7, 2023 2 $4.45K 4 Sep 8, 2023 Executive Chairman, Director
SGMT Sagimet Biosciences Inc. Jul 18, 2023 16 $0 4 Jul 20, 2023 Director
SGMT Sagimet Biosciences Inc. Jul 13, 2023 0 $0 3 Jul 13, 2023 Director